JEAN SEIGNON: Open Payments
NPI 1982808531 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 52 payments from 16 companies in 2025. Trend: 2023 $897 · 2024 $759 · 2025 $778
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $195 |
| Novo Nordisk Inc | 11 | $141 |
| ABBVIE INC. | 5 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $86 |
| Dexcom, Inc. | 3 | $48 |
| Exact Sciences Corporation | 2 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Dynavax Technologies Corporation | 1 | $18 |
Products named: TRELEGY ELLIPTA, JARDIANCE, SHINGRIX, VRAYLAR, Rybelsus, Ozempic, Dexcom G6 Transmitter, UBRELVY.
Industry payments across TX — which companies pay providers there.
